BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2192103)

  • 1. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S; Ohyanagi H; Saitoh Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of YH-206 assay analysis as a tumor marker].
    Yachi A; Hinoda Y; Imai K; Endo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T; Morimoto H; Saito M; Mori T
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract]   [Full Text] [Related]  

  • 6. A new monoclonal-antibody-defined tumor marker (KMO1) for pancreatic carcinoma.
    Ohyanagi H; Saitoh Y; Okumura S; Ishida T; Uesaka K; Ishida H; Yamamoto M; Uemura Y; Kano Y; Suyama T
    Mt Sinai J Med; 1987 Jun; 54(5):393-400. PubMed ID: 3498891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
    Sekine T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N; Satomura Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary free L-fucose (UFC) and urinary sulfated bile acids (U-SBA)].
    Mashige F
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():774-8. PubMed ID: 16149638
    [No Abstract]   [Full Text] [Related]  

  • 10. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 6). Application of tumor marker KM 01 analysis in the diagnosis of pancreatic neoplasms].
    Okumura S; Ohyanagi H; Saito Y
    Nihon Rinsho; 1986 Aug; 44(8):1834-42. PubMed ID: 3537375
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H; Sakawaki T
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023)].
    Sakurabayashi I; Kawai T; Omizo R; Hattori N; Ishii M
    Rinsho Byori; 1988 Dec; 36(12):1407-12. PubMed ID: 2854864
    [No Abstract]   [Full Text] [Related]  

  • 15. [CA72-4 (TAG-72)].
    Maida Y; Kyo S; Inoue M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K; Mitsuhashi F; Ohkura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of PIVKA-II in patients with hepatocellular carcinoma. Detection of PIVKA-II by EIA using anti-PIVKA-II monoclonal antibody].
    Ohtani M; Ido K; Kawamoto C; Kimura K
    Rinsho Byori; 1989 Apr; 37(4):405-9. PubMed ID: 2545953
    [No Abstract]   [Full Text] [Related]  

  • 18. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
    DelVillano BC; Zurawski VR
    Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pancreatic and biliary tract cancers].
    Sawada T; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):865-71. PubMed ID: 11432359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrasonic diagnosis of neoplasms of liver, biliary tract and pancreas].
    Kitamura T
    Nihon Rinsho; 1982; 40(1):71-8. PubMed ID: 7087207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.